Challenges in Clinical Cardiology: A Case-Based Update

Challenges in Clinical Cardiology

Challenges in Clinical Cardiology: A Case-Based Update

Loews Chicago Hotel, Chicago, IL

10/6/2017 - 10/8/2017

Add to Cart

$779 - $879

Overview

COURSE DESCRIPTION
This annual course is designed to provide a case-based update on the diagnosis and treatment of commonly encountered cardiovascular conditions. Expert faculty will focus on challenging aspects of coronary artery disease, atrial fibrillation, congestive heart failure, valvular heart disease, congenital heart disease, pulmonary hypertension, obstructive sleep apnea, and preventive cardiology. This case-based review will address the relevant guidelines and latest treatment options for patients with these conditions.

LEARNING OBJECTIVES
Upon completion of this course, participants should be able to:

  • Review diagnosis and treatment of heart failure with preserved ejection fraction
  • Describe diagnosis and treatment of high output heart failure and peripartum cardiomyopathy
  • Review current options for revascularization of coronary artery disease
  • Describe the approach to evaluation and treatment of myocardial infarction in setting of normal coronary arteries and following non-cardiac surgery
  • Review the J-shaped relationship of blood pressure control and clinical outcomes
  • Review the management of statin intolerance
  • Describe how to assess and manage patients with bicuspid aortic valve disease, mitral regurgitation, and severe tricuspid regurgitation
  • Describe how to assess a patient with a mechanical mitral valve replacement and high gradient
  • Review etiology of atrial fibrillation and factors influencing natural history
  • Review the role of aspirin therapy for stroke prevention in patients with atrial fibrillation
  • Review challenging cases and treatment decisions inpatients with atrial fibrillation
  • Describe an approach to the diagnosis and etiology of pacemaker dysfunctionR
  • Review the classification and treatment of pulmonary hypertension
  • Describe the available treatment options in patients with hypertrophic cardiomyopathy
  • Describe the diagnosis and management of cancer treatment related cardiotoxicity
  • Describe an approach to the diagnosis of refractory pericarditis
  • Review the risk factors for mortality in Eisenmenger syndrome

Attendance at this course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught at this course.

INTENDED AUDIENCE
This course is appropriate for, but not limited to, cardiologists, internal medicine subspecialists, general internists, physician assistants, nurse practitioners, and other primary healthcare providers.

Program

FRIDAY, OCTOBER 6, 2017

7:00 a.m. Registration and Continental Breakfast
7:50 a.m. Welcome and Introductions

Circulatory Failure
Session Moderator: Alfredo L. Clavell, M.D.

8:00 a.m. State-of-the-Art Lecture: Heart Failure with Preserved Ejection Fraction
Paul M. McKie, M.D.
8:30 a.m. High Output Heart Failure: Diagnosis and Approach to Treatment
Daniel D. Borgeson, M.D.
8:55 a.m. Peripartum Cardiomyopathy: Diagnosis and Management
Lori A. Blauwet, M.D.
9:20 a.m. How to Recognize Reversible Causes of Heart Failure
Alfredo L. Clavell, M.D.
9:45 a.m. Refreshment Break

Ischemic Heart Disease
Session Moderator: Eric H. Yang, M.D.
Surgical Perspective: Hartzell V. Schaff, M.D.

10:15 a.m. State-of-the-Art Lecture: Coronary Artery Disease - Surgical vs. Percutaneous Revascularization vs. Both - What Therapy is Best in 2017
J. Wells Askew, III, M.D.
10:40 a.m. STEMI with Normal Coronary Angiogram: Approach to Evaluation and Treatment
Amy W. Pollak, M.D.
11:05 a.m. Stress Testing
Todd D. Miller, M.D.
11:30 a.m. Asymptomatic Ischemia Despite Optimal Medical Therapy - Should We Revascularize?
Peter M. Pollak, M.D.
11:55 a.m. NSTEMI Following Non-Cardiac Surgery: Optimal Management
Eric H. Yang, M.D.
12:20 p.m. Lunch (provided)

General and Preventive Cardiology I
Session Moderator: Heidi M. Connolly, M.D.

1:30 p.m. Coronary Artery Vasospasm: Diagnosis and Treatment
Eric H. Yang, M.D.
1:55 p.m. Novel Risk Factors: Is It Worth Looking?
Francisco Lopez-Jimenez, M.D.
2:20 p.m. Obstructive Sleep Apnea: Does Treatment Actually Reduce Cardiovascular Events?
Sean M. Caples, D.O.
2:45 p.m. Descision Making in Geriatric Cardiology
Jorge A. Brenes-Salazar, M.D.
3:10 p.m. Refreshment Break

General and Preventive Cardiology II
Session Moderator: Francisco Lopez-Jimenez, M.D.

3:40 p.m. Statin Intolerance: Approach to Evaluation and Treatment
Francisco Lopez-Jimenez, M.D.
4:05 p.m. Promoting Cardiovascular Health: Same Strategy for Everyone?
LaPrincess C. Brewer, M.D., M.P.H.
4:30 p.m. Exercise in Patients with Structural Heart Disease: A Practical Approach
Jeffrey B. Geske, M.D.
4:55 p.m. Adjourn
5:00 - 6:00 p.m. Welcome Reception - Wright Foyer

SATURDAY, OCTOBER 7, 2017

7:00 a.m. Continental Breakfast
7:50 a.m. Welcome and Announcements

Valvular Heart Disease I
Session Moderator: Charles J. Bruce, M.D.
Surgical Perspective: Hartzell V. Schaff, M.D.

8:00 a.m. Approach to the Patient with Bicuspid Aortic Valve Disease in 2017
Heidi M. Connolly, M.D.
8:30 a.m.

When is Mitral Regurgitation Severe
Vuyisile T. Nkomo, M.D.

8:55 a.m. Severe Aortic Regurgitation: When to Intervene
Charles J. Bruce, M.D.
9:20 a.m. Valvular Heart Disease: How to Determine When Treatment is Futile
Cory Ingram, M.D.
9:45 a.m. Refreshment Break

Valvular Heart Disease II
Session Moderator: Heidi M. Connolly, M.D.
Surgical Perspective: Hartzell V. Schaff, M.D.

10:15 a.m. Mechanical Mitral Valve with High Gradient: What is Your Approach to Evaluation
Lori A. Blauwet, M.D.
10:40 a.m. Perivalvular Regurgitation: Diangosis and Management
Sorin V. Pislaru, M.D., Ph.D.
11:05 a.m. Does a Patient with Prior Mitral Valve Repair Require Endocarditis Prophylaxis?
Walter R. Wilson, M.D.
11:30 a.m. How to Diagnose Severe Tricuspid Regurgitation
Sorin V. Pislaru, M.D., Ph.D.
11:55 a.m. Lunch (provided)

Heart Rhythm Disorders I
Session Moderator: Christopher J. McLeod, M.B., Ch.B., Ph.D.

1:10 p.m. State-of-the-Art Lecture: Can Atrial Fibrillation be Prevented in 2017?
Peter A. Noseworthy, M.D.
1:35 p.m. CHADSVASC: Is Aspirin Indicated for Stroke Prevention in Atrial Fibrillation?
Suraj Kapa, M.D.
2:00 p.m. Atrial Fibrillation: Is Lifelong Anticoagulation Always Necessary?
Christopher J. McLeod, M.B., Ch.B., Ph.D.
2:25 p.m. Atrial Fibrillation: Challenging Cases and Treatment Decisions
  • Severely Decreased LVEF
  • Severe COPD/Asthma
  • WPW
  • HCM

Panel: Drs. Kapa, McLeod, and Noseworthy

3:15 p.m. Refreshment Break

Heart Rhythm Disorders II
Session Moderator: Christopher J. McLeod, M.B., Ch.B., Ph.D.

3:40 p.m. ICDs for Non-Ischemic Cardiomyopathy: Do They Alter Outcomes?
Suraj Kapa, M.D.
4:05 p.m. SubQ vs. Transvenous ICD
Christopher J. McLeod, M.B., Ch.B., Ph.D.
4:30 p.m. Cases of Pacemaker Dysfunction: Approach to Diagnosis
Michael J. Osborn, M.D.
4:55 p.m. Adjourn

SUNDAY, OCTOBER 8, 2017

7:00 a.m. Continental Breakfast
7:50 a.m. Welcome and Announcements

Cardiology Potpourri I
Session Moderator: Charles J. Bruce, M.D.

8:00 a.m. State-of-the-Art Lecture: Pulmonary Hypertension 2017: Approach to Diagnosis and Classification
Garvan C. Kane, M.D., Ph.D.
8:30 a.m. A Challenging Vascular Case
Robert D. McBane, M.D.
8:50 a.m. Familial Thoracic Aortic Aneurysm Disease: Recognition and Management
Heidi M. Connolly, M.D.
9:15 a.m. Hypertrophic Cardiomyopathy: Treatment Options When Beta Blockers and Calcium Antagonists Fail
Jeffrey B. Geske, M.D.
9:40 a.m. The J-Shaped Relationship of BP Control and Cardiovascular Outcomes
Stephen C. Textor, M.D.
10:05 a.m. Refreshment Break

Cardiology Potpourri II
Session Moderator: Heidi M. Connolly, M.D.

10:30 a.m. Refractory Pericarditis: Diagnosis and Treatment
Raul E. Espinosa, M.D.
10:55 a.m. Echo Pop Quiz: What is the Cardiac Mass?
Charles J. Bruce, M.D.
11:20 a.m. PFO Closure: Is the Debate Over

Peter M. Pollak, M.D.

11:45 a.m. Closing Comments
12:00 p.m. Adjourn

 

Faculty

COURSE DIRECTORS
Charles J. Bruce, M.D.
Heidi M. Connolly, M.D.

MAYO CLINIC FACULTY
J. Wells Askew, M.D.
Lori A. Blauwet, M.D.
Daniel D. Borgeson, M.D.
Jorge A. Brenes-Salazar, M.D.
LaPrincess C. Brewer, M.D., M.P.H.
Sean M. Caples, D.O., M.S.
Alfredo L. Clavell, M.D.
Raul E. Espinosa, M.D.
Jeffrey B. Geske, M.D.
Cory Ingram, M.D.
Garvan C. Kane, M.D., Ph.D.
Suraj Kapa, M.D.
Francisco Lopez-Jimenez, M.D.
Paul McKie, M.D.
Christopher J. McLeod, M.B., Ch.B., Ph.D.
Robert D. McBane, M.D.
Todd D. Miller, M.D.
Vuyisile T. Nkomo, M.D., M.P.H.
Peter A. Noseworthy, M.D.
Michael J. Osborn, M.D.
Sorin V. Pislaru, M.D., Ph.D.
Amy  W. Pollak, M.D.
Peter M. Pollak, M.D.
Hartzell V. Schaff, M.D.
Stephen C. Textor, M.D.
Walter R. Wilson, M.D. 
Eric H. Yang, M.D.


FACULTY DISCLOSURE
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development) must ensure balance, objectivity, and scientific rigor in its education activities. Course directors, planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclosure all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put into place. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

NATIONAL PHYSICIAN PAYMENT TRANSPARENCY PROGRAM
Mayo Clinic College of Medicine and Science complies with the requirements of the National Physician Payment Transparency Program OPEN PAYMENTS (Physician Payment Sunshine Act).

Credit

Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 17.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Health Care Professionals
A certificate of attendance will be provided to other health care professionals for requesting credit in accordance with state nursing boards, specialty societies, or other professional associations.

Attendees should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 CreditsTM from the sponsor of this activity.


MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared with ABIM through PARS.

Lodging

Guest rooms have been reserved for attendees and their guests at Loews Chicago Hotel. In order to receive the group rate, reservations must be made before the room block is filled or before the expiration date of September 14, 2017, whichever comes first. To secure the group rate, please specify you are with the Mayo Clinic Challenges in Clinical Cardiology conference.

Loews Chicago Hotel
455 North Park Drive
Chicago, IL 60611

Rate:  $289
Phone Reservations:  877-868-8232
Online Reservation Booking

Lodging arrangements are the sole responsibility of the individual registrant.

Mayo Clinic Cardiovascular CME is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registrant such as airline or hotel fees or penalties are the responsibility of the registrant.

Pricing

MD, PhD, DO, PharmD $879
Fellow, Resident, RN, NP, PA, Sonographer $779


The registration fee includes tuition, electronic course syllabus, continental breakfasts, break refreshments, and lunches. Although it is not Mayo Clinic Cardiovascular CME (CV CME) policy to limit the number of registrants for a course, conference room facilities may necessitate closing of enrollment; therefore, early registration is advised. Enrollment for this program is limited.

Mayo Clinic CV CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event Mayo Clinic CV CME must cancel or postpone this course, Mayo Clinic CV CME will refund the registration fee, but is not responsible for any relates costs, charges, or expenses to participants, including fees assessed by airlines/travel/lodging agencies.


CANCELLATION POLICY
If you cancel your participation in this course, your registration fee, less a $75 administration fee, will be refunded when written notification is received by Mayo Clinic CV CME before September 22, 2017 (email: cvcme@mayo.edu). No refunds will be made on or after September 22, 2017. Canceled registrations are non-transferable.

NO SHOW POLICY
This course is intended to be a live learning experience. If you do not attend this course on-site as a live learner, you will not be allowed access to the materials/lectures during or after the course. No refunds will be given for no-show registrants.

Exhibits

At the time of this posting, a complete listing of commercial support (financial or in-kind) was not available. Appropriate acknowledgement will be given to all supporters at the time of the meeting.

EXHIBIT OPPORTUNITIES
This course offers the opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Jessica Hemenway. Exhibits will be available for viewing at all scheduled breaks.


Back to top